Antonella Ferro

2.4k total citations
56 papers, 1.1k citations indexed

About

Antonella Ferro is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Antonella Ferro has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 18 papers in Cancer Research and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Antonella Ferro's work include HER2/EGFR in Cancer Research (14 papers), Breast Cancer Treatment Studies (13 papers) and Advanced Breast Cancer Therapies (8 papers). Antonella Ferro is often cited by papers focused on HER2/EGFR in Cancer Research (14 papers), Breast Cancer Treatment Studies (13 papers) and Advanced Breast Cancer Therapies (8 papers). Antonella Ferro collaborates with scholars based in Italy, United States and United Kingdom. Antonella Ferro's co-authors include Enzo Galligioni, Orazio Caffo, Mattia Barbareschi, F. Valduga, Paolo Palma, A. Lucenti, Maurizio Amichetti, Claudio Eccher, Antonio Marchetti and Fabio Barassi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Antonella Ferro

48 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonella Ferro Italy 18 426 320 239 233 135 56 1.1k
Wegene Borena Austria 19 333 0.8× 360 1.1× 455 1.9× 147 0.6× 50 0.4× 61 1.4k
Hongling Wang China 20 271 0.6× 482 1.5× 288 1.2× 198 0.8× 29 0.2× 58 1.6k
Karen Kopciuk Canada 22 697 1.6× 534 1.7× 285 1.2× 167 0.7× 18 0.1× 74 1.6k
Ke Wu China 22 342 0.8× 451 1.4× 304 1.3× 169 0.7× 13 0.1× 68 1.5k
Chaofan Li China 18 152 0.4× 293 0.9× 111 0.5× 153 0.7× 22 0.2× 73 1.1k
Ramya Ramaswami United States 22 722 1.7× 222 0.7× 249 1.0× 92 0.4× 13 0.1× 75 1.6k
Amy Brown United States 13 184 0.4× 328 1.0× 292 1.2× 105 0.5× 39 0.3× 34 1.9k
Bruce A. Feinberg United States 17 477 1.1× 173 0.5× 121 0.5× 249 1.1× 39 0.3× 145 1.2k
John H. Maduro Netherlands 29 678 1.6× 219 0.7× 939 3.9× 519 2.2× 51 0.4× 89 2.3k

Countries citing papers authored by Antonella Ferro

Since Specialization
Citations

This map shows the geographic impact of Antonella Ferro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonella Ferro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonella Ferro more than expected).

Fields of papers citing papers by Antonella Ferro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonella Ferro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonella Ferro. The network helps show where Antonella Ferro may publish in the future.

Co-authorship network of co-authors of Antonella Ferro

This figure shows the co-authorship network connecting the top 25 collaborators of Antonella Ferro. A scholar is included among the top collaborators of Antonella Ferro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonella Ferro. Antonella Ferro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Conté, Pierfranco, Maria Vittoria Dieci, Giancarlo Bisagni, et al.. (2024). A-BRAVE trial: A phase III randomized trial with avelumab in early triple-negative breast cancer with residual disease after neoadjuvant chemotherapy or at high risk after primary surgery and adjuvant chemotherapy.. Journal of Clinical Oncology. 42(17_suppl). LBA500–LBA500. 16 indexed citations
3.
Ferro, Antonella, Michela Campora, A. Caldara, et al.. (2024). Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer. Journal of Clinical Medicine. 13(12). 3611–3611. 8 indexed citations
4.
Gori, Stefania, Alberto Zambelli, Catia Angiolini, et al.. (2024). Follow-up of breast cancer: why is it necessary to start a Consensus in 2024?. SHILAP Revista de lepidopterología. 11(1). 10–17.
5.
Rose, Fiorenza De, Lucia Di Brina, L. Menegotti, et al.. (2023). Whole Breast Irradiation Versus Intraoperative Electron Radiation Therapy for Breast Conserving Therapy: A Large Mature Single Institution Matched-Pair Evaluation of True Local Relapse, Progression Free Survival, and Overall Survival. International Journal of Radiation Oncology*Biology*Physics. 116(4). 757–769. 3 indexed citations
6.
Ferro, Antonella, Daniele Generali, Orazio Caffo, et al.. (2023). Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice?. Seminars in Oncology. 50(3-5). 90–101. 6 indexed citations
7.
Rose, Fiorenza De, Bruno Meduri, Maria Carmen De Santis, et al.. (2022). Rethinking breast cancer follow-up based on individual risk and recurrence management. Cancer Treatment Reviews. 109. 102434–102434. 29 indexed citations
8.
Conté, Pierfranco, Antonio Frassoldati, Giancarlo Bisagni, et al.. (2021). 41O Nine weeks vs 1-year adjuvant trastuzumab: Long term outcomes of the ShortHER randomised trial. Annals of Oncology. 32. S37–S37. 4 indexed citations
9.
Ferro, Antonella, Carlos A. Garcia‐Etienne, Orazio Caffo, et al.. (2020). Management of Breast Cancer Patients during the COVID-19 Pandemic in Northern Italy. Breast Care. 16(4). 418–421. 1 indexed citations
10.
Murgia, Viviana, Antonello Veccia, S. Brugnara, et al.. (2017). Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer. Anti-Cancer Drugs. 28(6). 654–659. 1 indexed citations
11.
Galligioni, Enzo, Enrico Maria Piras, Claudio Eccher, et al.. (2015). Integrating mHealth in Oncology: Experience in the Province of Trento. Journal of Medical Internet Research. 17(5). e114–e114. 35 indexed citations
12.
Eccher, Claudio, et al.. (2013). An ontology of cancer therapies supporting interoperability and data consistency in EPRs. Computers in Biology and Medicine. 43(7). 822–832. 8 indexed citations
13.
Brunetto, Emanuela, Anna Maria Ferrara, Anna Maria Talarico, et al.. (2013). CDC25A Protein Stability Represents a Previously Unrecognized Target of HER2 Signaling in Human Breast Cancer: Implication for a Potential Clinical Relevance in Trastuzumab Treatment. Neoplasia. 15(6). 579–590. 17 indexed citations
14.
Caffo, Orazio, Giovanni Pappagallo, S. Brugnara, et al.. (2012). Multiple Rechallenges for Castration-resistant Prostate Cancer Patients Responding to First-line Docetaxel: Assessment of Clinical Outcomes and Predictive Factors. Urology. 79(3). 644–649. 42 indexed citations
15.
Ferro, Antonella, Claudio Eccher, A. Caldara, et al.. (2012). Invasive lobular (ILC) versus invasive ductal (IDC) breast cancer (BC): Clinical-pathologic features and clinical outcomes in monoinstitutional series.. Journal of Clinical Oncology. 30(15_suppl). e21102–e21102.
16.
Fasanella, Silvia, Elena Leonardi, Chiara Cantaloni, et al.. (2011). Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies. Diagnostic Pathology. 6(S1). S7–S7. 84 indexed citations
17.
Cantaloni, Chiara, Claudio Eccher, Luca Morelli, et al.. (2011). Diagnostic Value of Automated Her2 Evaluation in Breast Cancer. Applied immunohistochemistry & molecular morphology. 19(4). 306–312. 15 indexed citations
18.
Eccher, Claudio, Andreas Seyfang, Antonella Ferro, & Silvia Miksch. (2009). Embedding Oncologic Protocols into the Provision of Care: The Oncocure Project. Studies in health technology and informatics. 150. 663–7. 2 indexed citations
19.
Galligioni, Enzo & Antonella Ferro. (2001). Angiogenesis and antiangiogenic agents in non-small cell lung cancer. Lung Cancer. 34. 3–7. 21 indexed citations
20.
Iapichino, G., Danilo Radrizzani, Graziella Bonetti, et al.. (1985). Parenteral nutrition of injured patients: Effect of manipulation of aminoacid infusion (increasing branched chain while decreasing aromatic and sulphurated aminoacids). Clinical Nutrition. 4(3). 121–128. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026